Since the FDA approval of CA-125 as a tumor marker test, when a pelvic mass could be an ovarian carcinoma, clinicians are turning to this test as a tool in the diagnostic investigation.

In view of the possibility that the ovarian mass was a carcinoma, however, the tumor markers CA-125 and CA-19-9 were also ordered, and a gynecological oncology consult requested. The gynecological ...

They are known as undifferentiated or high grade. These cancers tend to grow and spread more quickly than low grade cancers. Doctors use different systems to grade epithelial ovarian cancer. It ...

Epithelial ovarian cancer is the most common type of ovarian cancer. Primary peritoneal cancer and fallopian tube cancer are similar to epithelial ovarian cancer and are treated in the same way. Germ ...

The results come two months after Merck shared positive results from the phase 3 KEYNOTE-689 trial of Keytruda as a ...

and high-grade serous ovarian carcinoma (HGSOC). Designed as a next generation FLT3 tyrosine kinase inhibitor, PHI-101 has a novel mechanism of action to overcome resistance to AML. In preclinical ...

In November 2024, CStone presented preclinical data for CS2009 at the 39th SITC Annual Meeting. These results show that CS2009 exhibits superior anti-tumor activity compared to potential competitors, ...

The Dr. Scott Kamelle Award for Ovarian Cancer Survivors stands as a beacon of hope and recognition for women who have overcome one of the most challenging health battles. This prestigious $1,000 ...